- Home
- ACRV vs JOF Comparison
ACRV vs JOF Comparison
Compare ACRV & JOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- JOF
- Stock Information
- Founded
- ACRV 2018
- JOF 1990
- Country
- ACRV United States
- JOF Japan
- Employees
- ACRV N/A
- JOF N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- JOF Trusts Except Educational Religious and Charitable
- Sector
- ACRV Health Care
- JOF Finance
- Exchange
- ACRV Nasdaq
- JOF Nasdaq
- Market Cap
- ACRV 247.8M
- JOF 214.2M
- IPO Year
- ACRV 2022
- JOF N/A
- Fundamental
- Price
- ACRV $6.44
- JOF $7.56
- Analyst Decision
- ACRV Strong Buy
- JOF
- Analyst Count
- ACRV 5
- JOF 0
- Target Price
- ACRV $22.40
- JOF N/A
- AVG Volume (30 Days)
- ACRV 46.9K
- JOF 43.9K
- Earning Date
- ACRV 11-13-2024
- JOF 01-01-0001
- Dividend Yield
- ACRV N/A
- JOF 3.33%
- EPS Growth
- ACRV N/A
- JOF N/A
- EPS
- ACRV N/A
- JOF N/A
- Revenue
- ACRV N/A
- JOF N/A
- Revenue This Year
- ACRV N/A
- JOF N/A
- Revenue Next Year
- ACRV N/A
- JOF N/A
- P/E Ratio
- ACRV N/A
- JOF N/A
- Revenue Growth
- ACRV N/A
- JOF N/A
- 52 Week Low
- ACRV $3.19
- JOF $6.64
- 52 Week High
- ACRV $11.90
- JOF $8.04
- Technical
- Relative Strength Index (RSI)
- ACRV 31.95
- JOF 41.44
- Support Level
- ACRV $6.11
- JOF $7.47
- Resistance Level
- ACRV $8.35
- JOF $7.67
- Average True Range (ATR)
- ACRV 0.48
- JOF 0.09
- MACD
- ACRV -0.23
- JOF -0.00
- Stochastic Oscillator
- ACRV 12.55
- JOF 25.71
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About JOF Japan Smaller Capitalization Fund Inc
Japan Smaller Capitalization Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.